Pittcon, Atlanta, Georgia, USA - 6 March 2016
Trajan Scientific and Medical (Trajan) is pleased to offer a sanctuary for wellbeing at Pittcon 2016, with professional massage therapists available at Booth 2556 to help delegates unwind from all the action of the conference.
Why? Trajan develops technologies to make a positive impact on human wellbeing.
In the spirit of wellness, Trajan’s booth this year draws attention to people, science and wellbeing.
However there is still room for technical details and development opportunities following last year’s unveiling of innovative technologies under the SGE brand.
Trajan continues to produce a range of analytical science consumables and components, while also extending their expertise and manufacturing capabilities to branch out into other fields of science and healthcare.
Chief Executive Officer of Trajan Stephen Tomisich said he was looking forward to reconnecting with longterm business partners, as well as forging new connections at Pittcon to discuss Trajan’s growing capabilities.
“From advanced photonics sensor technologies, expanding expertise in specialty glass forming and drawing, surface treatments and other areas, we are exploring new applications in analytical and medical devices.” said Mr Tomisich.
Trajan is increasing their presence in the Americas, relocating their current Austin, Texas office and warehouse this Spring, to a larger facility which will feature new production and kit assembly spaces.
The Trajan team is also growing with two recent additions in the US. Currently based out of Philadelphia, PA, is Mr Marc Neglia, Vice President of Sales for the Americas. Mr Neglia has an MBA from Drexel University, a Bachelor of Science (Electrical Engineering) from TESU, and over 20 years experience in relationship management, business development and sales in the scientific instrumentation market.
Mr Brian Jackson, has joined Trajan’s operations based in Austin, TX. He will focus on quality, process improvement, LEAN manufacturing and logistics. Complementary to his project management and production experience, Mr Jackson also has a Bachelor of Business Administration and Management from DeVry University.
On the opening of the exposition, Mr Tomisich said “Meet me and our team at Pittcon, to explore how we can work together to improve human wellbeing through science.”
Trajan Press Release [PDF]
Media contact information
Trajan Scientific and Medical
+61 (0) 3 9837 4200
In response to the COVID-19 pandemic, the biopharmaceutical industry has leapt into action to better understand the disease and develop suitable vaccines and therapies.
Trajan Scientific and Medical and Synexa Life Sciences have developed and validated an innovative, market-leading SARS-CoV-2 serology assay, available for high-throughput clinical research applications, using Trajan's advanced precision microsampling technology to expedite therapy and vaccine development as well as large-scale screening, sero-surveillance and post-market surveillance initiatives.
Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.
This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.